IL17A and allergic asthma: In a murine model of ovalbumin-induced allergic asthma, SCWE reduced the levels of IL-17 and granulocyte/macrophage colony-stimulating factor (GM-CSF) with reduction in the level of IL-4, which eventually decreased inflammatory cell infiltration and airway remodeling resulting clinical signs of allergic asthma (Kim et al., 2014).